Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1990 Dec;11(6):605-7.
doi: 10.1007/BF02337446.

24-month follow-up of multiple sclerosis patients treated with cyclophosphamide

E Millefiorini  1 , M Di Giovanni, S Bernardi, M G Grasso, A Di Giampietro, D Gambi
Affiliations
Clinical Trial

24-month follow-up of multiple sclerosis patients treated with cyclophosphamide

E Millefiorini et al. Ital J Neurol Sci. 1990 Dec.

Abstract

15 patients with remitting-progressive multiple sclerosis received a course of intravenous cyclophosphamide followed by a booster dose every 60 days for 2 years. There were no severe short or medium term side effects. Half of the patients presented clinical stabilization and substantially unchanged Kurtzke rating at 2 year follow-up. Since the aim was stabilization only, our findings argue for continuation of the study in young patients with very short shift.

PubMed Disclaimer

References

    1. Neurology. 1983 Nov;33(11):1444-52 - PubMed
    1. N Engl J Med. 1983 Jan 27;308(4):173-80 - PubMed
    1. Brain. 1980 Jun;103(2):281-300 - PubMed
    1. J Neurol. 1980;223(3):177-90 - PubMed
    1. J Neurol. 1983;230(2):73-80 - PubMed

Publication types

Substances

LinkOut - more resources